Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/43278
Title: Perioperative medicine and UK plc
Authors: Ackland, GL
Galley, HF
Shelley, B
Lambert, DG
First Published: 26-Oct-2018
Publisher: Elsevier
Citation: British Journal of Anaesthesia Volume 122, Issue 1, January 2019, Pages 3-7
Abstract: In March and May 2018, two open meetings were convened under the auspices of the National Institute of Academic Anaesthesia (NIAA) and National Institute of Health Research (NIHR) to consider how both clinical and non-clinical academics, research active National Health Service (NHS) clinicians, and industry representatives can continue to build on the investment underpinned by the NIAA in discovery science and experimental medicine. As an exemplar for drug discovery and experimental medicine, perioperative medicine has been transformed by extraordinary technological and pharmacological breakthroughs in both academia and industry, including Mapleson breathing circuits,propofol, the laryngeal mask airway, remifentanil, and sugammadex, to name a few. These advances have occurred, in comparison with many other specialties, at an astonishing pace. It is easy to overlook the impact of these huge technological leaps from the bench that have transformed anaesthetic—and wider—medical practice. Such innovation from industry, academia and the NHS are exemplars for the UK's ambition to secure health–life sciences as a pivotal industrial sector. Having reached, at least from a historical perspective, a likely plateau in progress in terms of technical equipment, there is an undeniable role for a new model of bi-directional, bedside-to-bench research contributing within the sphere of perioperative medicine, critical care, and pain medicine. As a potentially even more exciting era is emerging from both industrial and technological perspectives, here we consider the drivers that require discovery science and experimental medicine in anaesthesia to manoeuvre back into the fast lane of biomedical discovery.
DOI Link: 10.1016/j.bja.2018.09.023
eISSN: 1471-6771
Links: https://www.sciencedirect.com/science/article/pii/S0007091218307694?via%3Dihub
http://hdl.handle.net/2381/43278
Embargo on file until: 26-Oct-2019
Version: Post-print
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © 2018 British Journal of Anaesthesia. After an embargo period this version of the paper will be an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Description: The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.
Appears in Collections:Published Articles, Dept. of Cardiovascular Sciences

Files in This Item:
File Description SizeFormat 
BJA+Editorial+exp+med+R1++21.9.2018.pdfPost-review (final submitted author manuscript)212.28 kBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.